Resources from the same session
299MO - Efficacy and safety of entrectinib in an Asian population with <italic>NTRK</italic> fusion-positive (fp) solid tumours or <italic>ROS1</italic>-fp NSCLC
Presenter: Daniel Shao Weng Tan
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
300MO - Impact of dihydropyrimidine dehydrogenase (DPD) genotype on fluoropyrimidine-related toxicity in Asian population
Presenter: Masashi Kanai
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
301MO - Genomic HLA as a predictive biomarker for survival among non-small cell lung cancer patient treated with single agent immunotherapy
Presenter: Afaf Abed
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
302MO - Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors
Presenter: Jian-Guo Zhou
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
303MO - Single-cell analysis reveals the interaction between M2 macrophages and NK cells underlying immune types associated with cancer immunotherapy response
Presenter: Anlin Li
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
70MO - Efficacy and safety of envafolimab (KN035) in advanced tumours with mismatch-repair deficiency
Presenter: Jian Li
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Webcast
71MO - OBI-833 was safe and immunogenic, without treatment-related SAEs, in a phase I dose-escalation trial
Presenter: Her-shyong Shiah
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
72MO - Selinexor in combination with standard chemotherapy in patients with advanced solid tumours: Results of an open label, single-center, multi-arm phase Ib study
Presenter: Kyaw Thein
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
LBA3 - Early detection and localization of multiple cancers using a blood-based methylation assay (ELSA-seq)
Presenter: Qiang Gao
Session: Mini oral session on Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
Invited Discussant abstracts LBA3, 299MO and 300MO
Presenter: Chia-Chi Lin
Session: Mini oral session on Developmental and precision medicine
Resources:
Slides
Webcast